Tag: peripheral artery disease

CoreRx to formulate and manufacture JanOne’s peripheral artery disease candidate

pharmanewsdaily- February 7, 2020

JanOne has signed a manufacturing agreement with cGMP contract manufacturer CoreRx for the clinical formulation and manufacturing of its lead drug candidate TV1001SR, a potential ... Read More

Amarin bags Vascepa FDA approval for reducing cardiovascular risk

pharmanewsdaily- December 16, 2019

Vascepa FDA approval : New Jersey-based Amarin has secured approval from the US Food and Drug Administration (FDA) for a new indication and label expansion ... Read More

Symic Bio all set to begin peripheral artery disease drug trial

pharmanewsdaily- February 25, 2017

Symic Bio, a California based biopharma focued on matrix biology, is all set to begin the phase 1/2a clinical study named as SHIELD of its ... Read More